Accendra Health, Inc. ACH
Set alert
0.28 USD +0.02 +7.10%
As of Nov 3, 11:31 AM ET
0.2683 Day range 0.2898
0.19 52-week range 4.69
- YTD
- -89.92%
- 1 year
- -91.82%
- Open
- 0.28
- Prev close
- 0.2635
- Mkt cap
- 21.73M
- Vol
- 1.42M
- Avg vol
- 2.42M
- EPS
- -1.44
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.2683
- High
- 0.2898
- Forward P/E
- 2.40
- Beta
- 1.36
- Short ratio
- 0.00
- Inst. own
- 97.45%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Dec 25, 2024
- 50-d avg
- 0.00
- 200-d avg
- 0.00
- 1y target
- 5.44
MAX chart
Events in this range
- Mar 2, 1993Dividend: 0.08
- Jun 7, 2007Dividend: 0.376
- Sep 6, 2007Dividend: 0.497
Signals (61)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Mar 1, 2024 | 2 years ago |
| SMA: Bullish | Dec 1, 2023 | 2 years ago |
| MACD: Sell Signal | Mar 1, 2023 | 3 years ago |
| SMA: Bearish | Sep 1, 2022 | 4 years ago |
| SMA: Bearish | Jun 1, 2022 | 4 years ago |
| RSI: Overbought | Mar 1, 2021 | 5 years ago |
| SMA: Bullish | Sep 1, 2020 | 6 years ago |
| MACD: Buy Signal | Sep 1, 2020 | 6 years ago |
| SMA: Bullish | Jun 1, 2020 | 6 years ago |
| RSI: Oversold | Sep 1, 2018 | 8 years ago |
| RSI: Oversold | Dec 1, 2017 | 8 years ago |
| SMA: Bearish | Mar 1, 2017 | 9 years ago |
| SMA: Bearish | Mar 1, 2017 | 9 years ago |
| SMA: Bullish | Dec 1, 2016 | 9 years ago |
| SMA: Bearish | Jun 1, 2016 | 10 years ago |
| MACD: Sell Signal | Jun 1, 2016 | 10 years ago |
| MACD: Buy Signal | Dec 1, 2015 | 10 years ago |
| SMA: Bullish | Sep 1, 2015 | 11 years ago |
| SMA: Bearish | Mar 1, 2015 | 11 years ago |
| MACD: Sell Signal | Mar 1, 2015 | 11 years ago |
Newest 20 of 61.
Analyst view
Consensus: hold
Hold
Price target (mean) 5.44 +1827.7% upside
Now 0.2822
- Target (low)
- 4.00
- Target (mean)
- 5.44
- Target (high)
- 7.00
Ratings (0m) 5 1 buy · 2 hold · 2 sell
- Strong buy0
- Buy1
- Hold2
- Sell0
- Strong sell2
Recommendation trend
- This month 5
- 1 month ago 6
- 2 months ago 6
- 3 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.22235 | 0.22 – 0.23145 | 0.55 | -59.6% | 714.79M | -73.5% | 5 |
| Next quarter | 0.15329 | 0.14658 – 0.16 | 0.23 | -33.4% | 654.27M | -75.1% | 2 |
| Current year | 1.01 | 0.95 – 1.06 | 1.53 | -33.7% | 3.16B | -70.5% | 5 |
| Next year | 0.97202 | 0.82488 – 1.14 | 1.01 | -4.2% | 2.62B | -17.2% | 5 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 3, 2025 | UBS | Downgrade | Buy | Neutral |
| Aug 27, 2025 | JP Morgan | Maintained | Underweight | Underweight |
| Aug 13, 2025 | UBS | Maintained | Buy | Buy |
| Aug 12, 2025 | Baird | Maintained | Outperform | Outperform |
| Aug 12, 2025 | Citigroup | Maintained | Buy | Buy |
| Aug 12, 2025 | B of A Securities | Maintained | Underperform | Underperform |